4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001920738-26-000004
Chief Legal Officer sold 6,566 shares at $14.00 ($91,924)
- Chief Legal Officer acquired 6,566 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2026-06-30 | Option exercise 10b5-1 | +814 | $4.14 | $3,370 | 9,431 | D: show line 1 in the form |
| Bizily Scott Chief Legal Officer | 2026-06-30 | Option exercise 10b5-1 | +5,752 | $6.49 | $37,330 | 15,183 | D: show line 2 in the form |
| Bizily Scott Chief Legal Officer | 2026-06-30 | Sale 10b5-1 | −6,566 | $14.00 | $91,924 | 8,617 | D: show line 3 in the form |
| Open-market sales · 6,566 sh · avg $14.00 · $91,924 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2026-06-30 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −814 | 62,971 | D: show line 4 in the form | ||
| Bizily Scott Chief Legal Officer | 2026-06-30 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,752 | 3,543 | D: show line 5 in the form |
Loading xslF345X06/ownership.xml…